Last reviewed · How we verify

NCT05158647

Adding Magnesium Sulfate to Bupivacaine for Ilioinguinal and Iliohypogastric Nerve Block

Completed Phase 2 Last updated 15 December 2021
What this trial tests

Phase 2 trial testing normal saline in Magnesium Sulfate Causing Adverse Effects in Therapeutic Use in 90 participants. Completed in 21 April 2020.

Timeline
12 August 2018
Primary endpoint
7 February 2020
21 April 2020

Quick facts

Lead sponsorAbdelrady S Ibrahim, MD
PhasePhase 2
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingdouble
Primary purposeprevention
Enrollment90
Start date12 August 2018
Primary completion7 February 2020
Estimated completion21 April 2020
Sites1 location across Egypt

Drugs / interventions tested

Conditions studied

Sponsor

Abdelrady S Ibrahim, MD — full company profile →

Who can join

Eligibility, male only, with Magnesium Sulfate Causing Adverse Effects in Therapeutic Use. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Regional block of ilioinguinal and iliohypogastric (IIIH) nerves has been applied to provide postoperative analgesia after inguinal hernia repair. Magnesium sulfate (MgSo4) blocks N-methyl-d-aspartate receptors, and that is why, it was used as an adjuvant to the local anesthetic (LA) in different anesthetic approaches. Although the prolongation in postoperative duration resulting from the addition of MgSO4 to LA was significant in some literature studies, it was insignificant in others. This study was designed to investigate the adjunctive effect of MgSo4 when added to bupivacaine for IIIH blockade on the postoperative analgesic duration as a primary outcome and on the verbal rating scale (VRS) scores, analgesic consumption, and hemodynamics as secondary outcomes.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of normal saline

Trials testing the same drug.

Other Abdelrady S Ibrahim, MD trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05158647.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing